Children's Hyperactivity and Autism Research Treatment Study (CHARTS) A team of University of Rochester investigators is conducting the Children’s Hyperactivity and Autism Research Treatment Study (CHARTS) with a grant from the National Institute for Mental Health. This study focuses on the 1 in 4 children with Autism who also live with symptoms of ADHD, or Attention Deficit Hyperactivity Disorder. The study will evaluate the effectiveness of two treatments. One treatment is a medication called Atomoxetine (also called Strattera). This medication is intended to reduce symptoms of Attention Deficit Hyperactivity Disorder. The other treatment is called Parent Management Training (PMT). This training is intended to help parents learn how to manage their child’s challenging behaviors. The Rochester team is joined by counterparts at Ohio State University Medical Center and the University of Pittsburgh Medical Center. Together, the three sites will split the $3 million dollar award over five years. Learn more about about CHARTS, visit ClinicalTrials.gov. Who is Eligible to Participate? Children between 5-13 years old with a diagnosis of Autism Spectrum Disorder and ADHD. Contact Sarah Farash, LSW Phone: (585) 275-0953 Sarah_Farash@urmc.rochester.edu Currently Closed to Enrollment Project Collaborators Patricia Corbett-Dick, M.S., R.N., P.N.P. Susan L. Hyman, M.D. Suzannah Iadarola, Ph.D. Melissa Ryan, P.N.P. Laura Silverman, Ph.D. Tristram H. Smith, Ph.D. Laura Henrichs Cardella, M.D.